[1]
Gordon, K., Conrad, C., Lebwohl, M., Barker, J., Tsai, T.-F., Merola, J., Conrad, C., Zheng, M., Hu, N., Hofmann, P., Thoma, C. and Eyerich, K. 2023. Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s247. DOI:https://doi.org/10.25251/skin.7.supp.247.